PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY

NCT06354140 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
45
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University